Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Astellas
Astellas
Astellas Announces Positive Findings from Phase 3 GLOW Trial of Zolbetuximab during March ASCO Plenary Series
Drugs.com
Thu, 03/23/23 - 11:41 am
Astellas
zolbetuximab
clinical trials
gastric cancer
US again spurns march-in campaign to slash cost of Pfizer, Astellas' Xtandi
Fierce Pharma
Wed, 03/22/23 - 11:19 am
Pfizer
Astellas
Xtandi
prostate cancer
drug pricing
NIH
march-in rights
Pfizer and Astellas report positive data from prostate cancer therapy trial
Clinical Trials Arena
Fri, 03/17/23 - 10:02 am
Pfizer
Astellas
prostate cancer
clinical trials
Enzalutamide
leuprolide
Astellas Xospata comes up short again in bid to expand leukemia use
Fierce Pharma
Thu, 03/9/23 - 09:13 pm
Astellas
Xospata
AML
clinical trials
Astellas Presents Update on Recently Cleared Pompe Gene Therapy Trial
BioSpace
Thu, 02/23/23 - 10:36 am
Astellas
Pompe disease
clinical trials
AT845
Astellas has menopause accelerated approval ambition thwarted by FDA at last minute
Fierce Biotech
Mon, 02/20/23 - 12:19 pm
Astellas
menopause
fezolinetant
FDA
ASCO GU: Pfizer touts Talzenna's strong showing in PARP prostate cancer battle with AstraZeneca, J&J
Fierce Pharma
Fri, 02/17/23 - 09:36 am
ASCO GU
Pfizer
Astellas
Xtandi
prostate cancer
Astellas buys Super Bowl commercial spot to raise menopause awareness
Medical Marketing and Media
Sun, 02/12/23 - 07:36 pm
Astellas
menopause
Super Bowl
DTC advertising
television ads
fezolinetant
Astellas Taps New CEO in Nod to Accelerated Growth
BioSpace
Mon, 02/6/23 - 10:56 am
Astellas
Pharma CEOs
Naoki Okamura
Sandoz signs deal for antifungal from Astellas in buff-up of anti-infectives portfolio
Endpoints
Wed, 01/25/23 - 10:44 am
Sandoz
Novartis
Astellas
antifungals
Mycamine
generics
Astellas, after years of gene therapy woes, gets rare boost with FDA lifting of Pompe clinical hold
Fierce Biotech
Fri, 01/20/23 - 10:24 am
Astellas
Pompe disease
gene therapy
AT845
ASCO-GI 2023 – zolbetuximab opens up a stomach cancer niche
EP Vantage
Fri, 01/20/23 - 10:19 am
ASCO-GI
zolbetuximab
cancer of the gastro-esophageal junction
Astellas
Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug
Stat
Wed, 01/11/23 - 10:51 am
cancer
oncology
Joe Biden
Astellas
Xtandi
prostate cancer
Astellas loses bid to block Lexiscan generics in US
Pharmaphorum
Wed, 01/4/23 - 05:15 pm
legal
Astellas
Pfizer
Lexiscan
patents
Astellas’ Phase III gastric cancer therapy trial meets primary endpoint
Clinical Trials Arena
Fri, 12/16/22 - 10:21 am
Astellas
clinical trials
zolbetuximab
gastric cancer
Astellas' $1.3B antibody strikes first in hot cancer field, extending survival in phase 3
Fierce Biotech
Thu, 11/17/22 - 10:37 am
Astellas
zolbetuximab
clinical trials
cancer
gastric cancer
What causes hot flashes? Astellas ramps up educational campaign ahead of FDA decision
Endpoints
Wed, 11/2/22 - 11:00 pm
Astellas
hot flashes
menopause
fezolinetant
patient education
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma Dive
Tue, 11/1/22 - 07:09 pm
gene therapy
M&A
Akouos
AGTC
Taysha Gene Therapies
Astellas
Eli Lilly
Syncona
Astellas Pays $50M for Access to Taysha's Rett, GAN Programs
BioSpace
Wed, 10/26/22 - 10:29 am
Taysha Gene Therapies
Astellas
gene therapy
Rett Syndrome
GAN
Astellas takes stake in gene therapy developer Taysha
BioPharma Dive
Mon, 10/24/22 - 11:12 pm
Astellas
Taysha Gene Therapies
gene therapy
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »